Other combined CAR T cell products targeting different antigens, such as CD19/CD79b CAR T cells for B-NHL, CD19/CD38, CD19/CD123 CAR T cells for B-ALL, and BCMA/GPRC5D CAR T cells for MM, are being explored (182). Here, TNFRSF17 is linked to Miyoshi myopathy.